Skip to main content
Screener/Healthcare/Biotechnology

AVBP — ArriVent BioPharma, Inc.

NASDAQ
$14.88-13.57 (-47.70%)
$17.00
$35.83
$11.36
$15.79
EPS (TTM)$-3.53
P/E Ratio-6.95
Dividend Yield—
Market Cap$1.32B
Volume15.78M
Prev Close$28.46
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$0-$43.3M$-0.96——
Q4 '25$0-$35.5M$-0.84——
Q3 '25$0-$35.0M$-0.83——
Q2 '25$0-$31.4M$-0.90——
Q1 '25$0-$64.4M$-1.90——
Q4 '24$0-$20.6M$-0.61——
Q3 '24$0-$20.6M$-0.61——
Q2 '24$0-$21.9M$-0.65——
Get Your Daily Market Recap